AVR 0.00% $14.25 anteris technologies ltd

article gradasil 23feb 2015, page-22

  1. 5,330 Posts.
    lightbulb Created with Sketch. 32

    Another prophylactic Human Papillomavirus vaccine which as highlighted in the article, "in theory could prevent 90 percent of cervical cancers, compared to the 70 percent Gardasil currently stops."

    I can just imagine 50% of the world's population of 12yo girls living in developed countries would've erupted into a trancelike state of delight after hearing this news. As for the hundreds of millions of other people around the world today already living with HPV, this news means diddly squat...

    ... At least until a promising therapeutic HPV vaccine comes along such as the one that Advaxis are developing which has only just received another $23 million in the last week...

    That should keep the naysayers happy for the moment, provided they continue to ignore this information
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$14.25
Change
0.000(0.00%)
Mkt cap ! $301.2M
Open High Low Value Volume
$14.20 $14.76 $13.70 $355.0K 25.04K

Buyers (Bids)

No. Vol. Price($)
1 988 $14.25
 

Sellers (Offers)

Price($) Vol. No.
$14.99 1000 1
View Market Depth
Last trade - 16.10pm 12/08/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.